Double-blind, multicenter, prospective randomized study of trospectomycin vs. clindamycin, both with aztreonam, in non-community acquired obstetric and gynecologic infections

Infectious Diseases in Obstetrics and Gynecology

Volumn 5, Issue 4, 1997, Pages 280-285

  Chatwani, Ashwin ^a,f   Martens, Mark ^b   Blanco, Jorge ^c   Gall, Stanley ^d   Przybylko, Kira ^a   Wajszczuk, Charles P ^e   Nickens, Dana ^e  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c LBJ General Hospital   (United States)

^d University of Louisville School of Medicine   (United States)

^e PFIZER INC   (United States)

^f RS ^*  (United States)

Author keywords

Aztreonam; Clindamycin; Trospectomycin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALEXIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; TROSPECTOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CELLULITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRITIS; FEMALE; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031425874     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-0997(1997)5:4<280::AID-IDOG4>3.0.CO;2-0     Document Type: Conference Paper

References (14)

1. Sweet RL: Anaerobic infections of the female genital tract. Am J Obstet Gynecol 122:891, 1975.
2. Sweet RL, Ledger WJ: Puerperal infections morbidity: A two year review. Am J Obstet Gynecol 177:1903, 1973.
3. Ledger WJ, Normal J, Gee C, et al.: Bacteremia on an obstetrical gynecologic service. Am J Obstet Gynecol 121:205, 1975.
4. Thadepalli H, Gorback SL, Keith L: Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects. Am J Obstet Gynecol 117:1034, 1973.
5. Gibbs RS: Infection after cesarean section. Clin Obstet Gynecol 28:697, 1985.
6. Stovall TG, Thorpe EM, Ling FW: Treatment of postcesarean section endometritis with ampicillin and sulbactam or clindamycin and gentamicin. J Reprod Med 38:843, 1993.
7. Eschenbach DA, Wagner GP: Puerperal infections. Obstet Gynecol 23:1003, 1980.
8. Eschenbach DA, Buchanan TM, Pollock HM, et al.: Polymicrobial etiology of acute pelvic inflammatory diseases. N Engl J Med 293:166, 1975.
9. Duff P: Prophylactic Antibiotics for Hysterectomy. In Mead PB, Hager WD (eds): Infection Protocols for Obstetrics and Gynecology. Montrale, NJ: Medical Economics Publishing, p 277, 1995.
10. George WL, Sutter VL, Finegold SM: Antimicrobial agent-induced diarrhea bacterial disease. J Infect Dis 136:822, 1977.
11. Ledger WJ, Puttler OL: Death from pseudomembranous colitis. Obstet Gynecol 45:609, 1975.
12. Zurenko GE, Yagi BH, Vavra JJ, Wentworth BB: In vitro antibacterial activity of trospectomycin (U-63366F), novel spectinomycin analog. Antimicrob Agents Chemother 32:216, 1988.
13. Betty H, Yagi BH, Schaadt RD, Zurenko GE: The bacterial activity and post-antibiotic effect of trospectomycin. Diagn Microb Infect Dis 15:417, 1992.
14. Applebaum PC, Spangler SK, Jacobs MR: Susceptibility of 539 gram positive and gram negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam. J Antimicrob Chemother 32:223, 1993.